Filter Coffee
Search
Search
Loading...
Search
Loading...

Bite-sized insights for the
everyday investor

Each morning we send a fun to read free email packed with hot trends, startup signals and tech news

The Latest

View All

Why Brazil is Biocon’s next big pharma bet
News

Why Brazil is Biocon’s next big pharma bet

Biocon has landed a 10-year Pertuzumab partnership in Brazil, giving it a foothold in a healthcare market worth around $135 billion. Here’s what makes the deal significant.

Coffee Crew  |  Sep 8, 2026
Newsletter

Old monk caught in 4K 🔍

Coffee Crew  |  Sep 8, 2026
News

What’s behind India’s ₹1.10 lakh crore defence bet?

Coffee Crew  |  Sep 7, 2026
stories

Money in the few

Coffee Crew  |  Sep 7, 2026
News

Novartis bets ₹1,250 crore on Pfizer brands. Here’s why India is the real prize

Coffee Crew  |  Sep 7, 2026
stories

BSE brings Saatvik investing to the stock market

Coffee Crew  |  Sep 7, 2026

Editor's Choice

View All

How Google-backed Pixxel landed a $100 million bet
News
How Google-backed Pixxel landed a $100 million betCoffee Crew | Sep 7, 2026
Newsletter
UltraTech wires up a new fight 👊Coffee Crew | Sep 7, 2026
Why is TCS pouring in ₹70,000 crore on AI?
News
Why is TCS pouring in ₹70,000 crore on AI?Coffee Crew | Sep 6, 2026

Bite-sized insights for the everyday investor

no spam, no bs ☝️